Global Human Chorionic Gonadotropin (hCG) Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027

The global human chorionic gonadotropin (hCG) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to fuel the growth of the market include the rising burden of infertility and hypogonadism globally. Moreover, increasing awareness about hCG among healthcare professionals and patients, coupled with the new product launches, is anticipated to accelerate the market growth during the forecast period. Moreover, the continuous R&D in gonadotropin extraction and preparation, coupled with favourable initiatives by the government and non-government organizations, are some other factors, that are anticipated to propel the growth of the market globally. However, the availability of substitutes and side effects associated with hCG is a factor that is anticipated to hinder the market growth during the forecast period.

To Request a Sample of our Report on Global Human Chorionic Gonadotropin (hCG) Market: https://www.omrglobal.com/request-sample/human-chorionic-gonadotropin-hcg-market

The human chorionic gonadotropin hormone is a placental hormone secreted by syncytiotrophoblast cells during pregnancy. These hormones stimulate the corpus luteum to produce progesterone. Moreover, the naturally extracted or recombinant human chorionic gonadotropin hormones are used in the treatment of infertility, male hypogonadism, and many other conditions. Furthermore, human chorionic gonadotropin is used as the marker in cancer, including choriocarcinoma, seminoma, germ cell tumors, and others.

hCG hormone plays a vital role after the formation of the embryo. Hence the usage of hCG in infertility treatment gained traction in both men and women. The growing burden of infertility across the globe is one of the factors that is anticipated to accelerate market growth. The recombinant hCG products are anticipated to have significant growth owing to the availability of different strengths and dosages for the individualization of therapy. Moreover, the demand for naturally extracted HCG hormone products is also on the rise, owing to the launch of new products and significant adoption.

Market Coverage

· The market number available for – 2020-2027

· Base year- 2020

· Forecast period- 2021-2027

· Segment Covered

· Regions Covered- Globally

· Competitive Landscape: Merck & Co., Inc., Ferring B.V., and Fresenius SE & Co. KGaA, among others.

(Get 15% Discount on Buying this Report)

A full Report of Global Human Chorionic Gonadotropin (hCG) Market is Available at: https://www.omrglobal.com/industry-reports/human-chorionic-gonadotropin-hcg-market

Global Human Chorionic Gonadotropin (hCG) Market Report by Segment

By Technology

• Natural Source Extraction

• Recombinant

By Therapeutic Area

• Female Infertility Treatment

• Oligospermic

• Male Hypogonadism

• Others

Global Human Chorionic Gonadotropin (hCG) Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.